Aktiv Pharma Group

Aktiv Pharma Group is a rapidly growing specialty pharmaceutical company developing, manufacturing and commercialising sterile injectable products in a portfolio of proprietary, value-added, glass-free,
prefilled delivery systems. Aktiv is establishing itself as a vertically integrated contract design and manufacturing organisation with a unique combination of product competencies that specifically target biopharmaceuticals.

The company’s facilities in Colorado (US) include device; chemistry, manufacturing and controls; and manufacturing equipment development labs, as well as assembly cleanrooms and sterile fill-finish suites operated under cGMP.

Its portfolio of glass-free container closure systems and delivery systems includes substitutes for glass vials, prefilled syringes, reconstitution syringes, intravenous closed transfer systems, intranasal delivery systems, wearable injectors and autoinjectors. It has numerous contracts with the US government, including on the development of its glass-free autoinjector, ARIA.

Aktiv (previously known as Aktivax) was founded in 2008 and is privately owned. Its team of about 70 employees is anticipated to double in 2023, and triple to over 200 in 2024.

What's this?